High-Mobility Group Box 1 Protein (HMGB1) as a Novel Diagnostic Tool for Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome

Archives of Dermatology
doi 10.1001/archdermatol.2011.239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

JAMA Dermatology
DermatologyMedicine
2015English

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Oncologic Considerations

Clinical Journal of Oncology Nursing
Oncology
2004English

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Zonisamide

Clinical Case Reports
Medicine
2017English

New Insights in Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis Syndrome

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

The Current Understanding of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Expert Review of Clinical Immunology
AllergyImmunology
2011English

Pediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the United States

Journal of the American Academy of Dermatology
Dermatology
2017English

019 Serum RIP3 Level as a Severity-Predictive Marker for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Analisis Cost of Illness Stevens Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN)

Jurnal Pharmascience
2020English

Erratum to : Stevens-Johnson Syndrome (SJS)/toxic Epidermal Necrolysis (TEN): Diagnosis and Therapy

Journal of the Japanese Society of Intensive Care Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy